文献速递其他结缔组织病

系统性硬化症合并肺纤维化与肺气肿综合征:高发病率与高死亡率相关

Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality.
PubMed 文献 · Semin Arthritis Rheum · 2018-10-13

这项回顾性多中心病例对照研究纳入36例系统性硬化症(SSc)合并肺纤维化与肺气肿(CPFE)患者,与72例无肺气肿的SSc相关间质性肺病(ILD)对照比较。CPFE在SSc患者中占3.6%,在SSc-ILD中占7.6%;CPFE患者男性、吸烟者及局限皮肤型更多,DLCO更低,随访中肺动脉高压(PH)、非计划住院更多且生存更差。

要点

  • SSc患者中CPFE占3.6%,SSc-ILD中占7.6%。
  • CPFE患者更多为男性、吸烟者及局限皮肤型SSc。
  • CPFE患者DLCO更低,随访中PH与非计划住院更多、生存更差。

核心结论

  • CPFE综合征是SSc中一种独特的肺部表现,与更高的发病率和死亡率相关。
  • 对SSc患者(尤其吸烟者)通过胸部CT早期诊断CPFE,可能有助于早期戒烟、筛查PH和适当管理。

研究设计与样本

  • 回顾性多中心病例对照研究,纳入36例SSc合并CPFE患者,与72例无肺气肿的SSc-ILD对照比较。

主要发现

  • CPFE在SSc患者胸部CT中占3.6%,在SSc-ILD患者中占7.6%。
  • CPFE-SSc患者男性比例75% vs 18%(p<0.0001),吸烟者83% vs 33%(p<0.0001),局限皮肤型53% vs 24%(p<0.01)。
  • 诊断时CPFE-SSc患者DLCO为预测值的39±13% vs 51±12%(p<0.0001),肺总量和用力肺活量相似。
  • 随访中CPFE-SSc患者更常发生毛细血管前PH(44% vs 11%,p<10-4),非计划住院更频繁(50% vs 25%,p<0.01)。
  • Kaplan-Meier生存分析显示CPFE-SSc患者生存下降(p<0.02)。

临床怎么用

  • 对SSc患者尤其吸烟者应通过胸部CT早期识别CPFE,以促进戒烟、筛查PH并优化管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The syndrome of combined pulmonary fibrosis and emphysema (CPFE) primarily due to tobacco smoking has been reported in connective tissue disease, but little is known about its characteristics in systemic sclerosis (SSc). METHODS: In this retrospective multi-center case-control study, we identified 36 SSc patients with CPFE, and compared them with 72 SSc controls with interstitial lung disease (ILD) without emphysema. RESULTS: Rate of CPFE in SSc patients with CT scan was 3.6%, and 7.6% among SSc patients with ILD. CPFE-SSc patients were more likely to be male (75 % vs 18%, p < 0.0001), smokers (83 % vs 33%, p < 0.0001), and to have limited cutaneous SSc (53 % vs 24% p < 0.01) than ILD-SSc controls. No specific autoantibody was significantly associated with CPFE. At diagnosis, CPFE-SSc patients had a greater decrease in carbon monoxide diffusing capacity (DLCO 39 ± 13 % vs 51 ± 12% of predicted value, p < 0.0001) when compared to SSc-ILD controls, whereas lung volumes (total lung capacity and forced vital capacity) were similar. During follow-up, CPFE-SSc patients more frequently developed precapillary pulmonary hypertension (PH) (44 % vs 11%, p < 10-4), experienced more frequent unscheduled hospitalizations (50 % vs 25%, p < 0.01), and had decreased survival (p < 0.02 by Kaplan-Meier survival analysis) as compared to ILD-SSc controls. CONCLUSIONS: The CPFE syndrome is a distinct pulmonary manifestation in SSc, with higher morbidity and mortality. Early diagnosis of CPFE by chest CT in SSc patients (especially smokers) may result in earlier smoking cessation, screening for PH, and appropriate management.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Champtiaux N, Cottin V, Chassagnon G, et al. Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality. Semin Arthritis Rheum. 2018. PMID: 30409416. doi:10.1016/j.semarthrit.2018.10.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。